McKesson to Present Quality Initiative Study at ASCO 2010 Annual Meeting | McKesson Corp.
LinkedIn Login

Connect healthcare products, companies and hospitals with your LinkedIn network.

Facebook Login

Interact with your Facebook network around healthcare products, companies and hospitals.

Login With Facebook
MedicExchange Login

Enjoy Premium Access as a MedicExchange Member.

       Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Facebook Twitter Linkedin
Facebook: MedicExchange
Twitter: MedicExchange
McKesson McKesson to Present Quality Initiative Study at ASCO 2010 Annual Meeting

McKesson to Present Quality Initiative Study at ASCO 2010 Annual Meeting

Company News - McKesson Corp.

Innovative technology used to gather physician feedback in evaluating bisphosphonate use.

Onmark , a leading national group purchasing organization ( GPO ) for community-based practices and a McKesson Specialty Care Solutions company, today announced it will present a clinical abstract based on a study featuring physician feedback on the evaluation of bisphosphonate use. Results from the study will be presented at the 46th Annual Meeting of the American Society of Clinical Oncology ( ASCO ) at McCormick Place in Chicago from June 4-8, 2010.

In the study, McKesson Specialty Care Solutions investigated a quality initiative across its Onmark membership of community oncology practices nationwide which measures intravenous bisphosphonate compliance and provided clinical education using Web-based drug dispensing technology with interactive physician queries.

"Our innovative Lynx® technology platform allowed us to capture physician feedback related to evaluating a key quality initiative in oncology," said Kim Bergstrom, Pharm.D., Chief Clinical Officer at McKesson Specialty Care Solutions. "McKesson’s commitment to clinical and technology innovation is highlighted through this abstract submission. Our experienced clinical team focuses on integrating clinical topics such as quality care and guideline adherence with technology advancements to drive community oncology forward."

Poster Presentation Information:

-------------------------

Abstract Title : Innovative quality initiative measurement using web-based drug dispensing technology with interactive physician queries to evaluate bisphosphonate use across community oncology practices nationwide.

Poster Session Date/Time : Monday, June 7 from 1:00pm – 5:00pm

Permanent Abstract ID : 9070

Location : S Hall A2, Board #43C

The full abstract can be accessed through the ASCO website . The complete poster will also be available on the Onmark website, www.onmarkservices.com following the presentation. Additional information will be available at the McKesson/Onmark ASCO Booth #12107.

Source: McKesson